Aeon welcomed the establishment of the Dubai Longevity Authority (DLA), saying the move could accelerate innovation across the emirate’s healthcare sector.
The announcement frames the DLA as reinforcing Dubai’s D33 Agenda to position the city as a global destination for preventive healthcare, healthy ageing and longevity science.
The company describes Aeon as one of the region’s leading longevity clinics and claims it combines diagnostic testing with personalized regenerative therapies.
Services highlighted in the release include comprehensive biomarker testing, DNA sequencing, cellular health profiling and bespoke treatments ranging from intravenous therapies to cellular regeneration.
The announcement positions clinics such as Aeon as potential partners in adopting evidence-based longevity and regenerative medicine practices to support the new authority’s objectives.
